Background
Vitamin A deficiency is a public health problem in more than half of all countries, especially in Africa and Southeast Asia, and it especially affects young children and pregnant women in low-income countries. The numbers associated with this problem are staggering. Two hundred and fifty million preschool children are Vitamin A deficient, and every year, 250,000 to 500,000 Vitamin A deficient children become blind. Over half of them die with 12 months of the onset of blindness. It is also a major cause of maternal mortality. Another major causes of malnutrition in developing nations is Vitamin C deficiency. It is most prevalent in south east asia in the countries of India and Pakistan. The reason is a simple one.
We aim to combat this tragic and preventable loss of life by designing a strain of yeast that can produce a Vitamin A precursor, beta-carotene, that our body can convert into vitamin A in large enough quantities that it meets the daily required amounts. We also aim to install a vitamin C biosynthesis pathway in yeast. We hope that by doing this, we will be able to introduce Vitamin C into staples that people eat and drink, such as bread and beer, at no extra cost, as yeast are already used in these processes.
An important aspect of the VitaYeast project is to be able to regulate the amount of β-carotene and Vitamin C in our final food products. As overexpressing the enzymes in our pathways to a great degree would over-stress our yeast, we need to be able to optimally regulate the amount of each vitamin in order to maintain viable yeast that is maximally beneficial to the consumer. Therefore, it is crucial to have a system by which we can measure baseline kinetic rates of enzymes and substrates/products in the cell, make modifications to our system accordingly, and measure their impact accordingly. These quantitative experiments would prove to be crucial for optimizing our yeast strains and producing maximally efficient bread.